Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial. - Markert,J.M.; Medlock,M.D.; Rabkin,S.D.; Gillespie,G.Y.; Todo,T.; Hunter,W.D.; Palmer,C.A.; Feigenbaum,F.; Tornatore,C.; Tufaro,F.; Martuza,R.L. (Gene Ther, 2000)